




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Interventions and Vascular Medicine</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=4e7de144-8d5e-4458-886d-76ce2c5a0b66</link>
        <description>Clinical Topic Feed: Interventions and Vascular Medicine</description>
        <language>en</language>

        

                <item>
                    <title>Variation in Decision Moments and PE Diagnostic Yield in the ED</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/09/29/12/22/Variation-in-Decision-Moments</link>                    <description>Variation in deciding to test for pulmonary embolism (PE) across emergency department (ED) clinicians was associated with diagnostic yield, according to a retrospective study recently published in JAMA Network Open.</description>
                    <pubdate>1790690520000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>HI-PEITHO and the Evolution of Reperfusion Strategies in Pulmonary Embolism</title>
<link>/Latest-in-Cardiology/Articles/2026/09/08/14/17/HI-PEITHO-and-the-Evolution-of-Reperfusion-Strategies-in-Pulmonary-Embolism</link>                    <description>Management of intermediate-risk pulmonary embolism (PE) remains one of the most challenging areas in venous thromboembolism care. These patients are hemodynamically stable but have right ventricular (RV) dysfunction and myocardial injury, placing them at increased risk of clinical deterioration.</description>
                    <pubdate>1788962340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Top Trials from ESC 26</title>
<link>/Latest-in-Cardiology/Articles/2026/09/09/13/47/eagles-eye-view-09sep2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at some of the important trials presented at this year&#226;€™s European Society of Cardiology (ESC) Congress.</description>
                    <pubdate>1788961680000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC in a Flash | Persistent Excess CV Mortality in Black Americans; TAVR at 10 Years; More</title>
<link>/Latest-in-Cardiology/Articles/2026/09/01/01/JACC-in-a-Flash</link>                    <description>Featured topics and Editors&#39; Picks from all of ACC&#39;s JACC Journals.</description>
                    <pubdate>1788264600000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>CorCal Outcomes, EVAOLD, ISOLEDS Inform CV Risk Prediction, Post-MI Treatment and Stenting Strategies</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/mon-730am-corcal-evaold-isoleds-esc-2026</link>                    <description>Cardiovascular prevention, acute care and interventional cardiology converged in a wide-ranging Hot Line Session at ESC Congress 2026 that delivered new evidence on how clinicians assess risk, treat older heart attack patients and guide complex coronary procedures.</description>
                    <pubdate>1788177780000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>NATURE Superiority: Stent Retriever Thromboectomy Plus PCI in Patients With MI</title>
<link>/Latest-in-Cardiology/Articles/2026/08/24/12/30/sat-nature-esc-2026</link>                    <description>Compared with conventional PCI alone, stent-retriever thrombectomy followed by PCI was associated with reduced infarct size in patients with large thrombus burden undergoing primary PCI less than eight hours from symptom onset, based on findings from the NATURE Superiority study presented at ESC Congress 2026 and simultaneously published in JACC.</description>
                    <pubdate>1788016800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>AIR-STEMI, PRESC1SE-MI and TARGET CTA Highlight Critical Care Cardiology Science</title>
<link>/Latest-in-Cardiology/Articles/2026/08/24/12/30/sat-11am-combo-ccc-esc-2026</link>                    <description>Researchers presenting findings from the AIR-STEMI trial at ESC Congress 2026 said a strategy of complete coronary artery revascularization guided by functional coronary angiography resulted in a lower risk of death, myocardial infarction (MI), cerebrovascular accident, or ischemia-driven revascularization in patients with STEMI and multivessel coronary artery disease compared with conventional angiography.</description>
                    <pubdate>1788016560000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Interventional Highlights From LIBREXIA ACS, PREMIUM, SWITCH SWEDEHEART, A-CLOSE, EPIDAURUS</title>
<link>/Latest-in-Cardiology/Articles/2026/08/24/12/30/sat-6am-combo-interventional-esc-2026</link>                    <description>Interventional science was the focus of a Hot Line Session at ESC Congress 2026, with studies shedding light on milvexian with antiplatelet therapy following an acute coronary event; aspirin omission at the time of primary PCI in STEMI; switching from ticagrelor to prasugrel following PCI in patients with acute coronary syndrome (ACS); clopidogrel vs. extended DAPT after high-risk PCI; and potent antiplatelet therapy in patients with atrial fibrillation (AFib) following myocardial infarction (MI).</description>
                    <pubdate>1788005340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC Journals&#226;€™ Abstracts Explore Novel Therapies, Role of Precision Medicine, and More</title>
<link>/Latest-in-Cardiology/Articles/2026/08/24/12/30/sat-jacc-journals-esc-2026</link>                    <description>Several abstracts and e-posters presented at ESC Congress 2026 and simultaneously published across the JACC family of journals highlight the expanding role of precision medicine, novel therapeutics, and advanced risk stratification across cardiovascular care.</description>
                    <pubdate>1788002340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: ACC Updated Expert Consensus Decision Pathway on HFpEF</title>
<link>/Latest-in-Cardiology/Articles/2026/07/29/13/18/eagles-eye-view-29jul2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at a post-hoc analysis of the API-CAT trial that showed recurrent venous thromboembolism (VTE) is uncommon but associated with poor short-term survival of patients with cancer-associated thrombosis.</description>
                    <pubdate>1785331140000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>